Page last updated: 2024-08-22

butylhydroxybutylnitrosamine and Innate Inflammatory Response

butylhydroxybutylnitrosamine has been researched along with Innate Inflammatory Response in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Akane, H; Cho, YM; Matsushita, K; Morikawa, T; Ogawa, K; Toyoda, T; Yamada, T1
Degoricija, M; Haupt, B; Ivanisevic, T; Karaman, I; Korac-Prlic, J; Palada, V; Petkovic, M; Terzic, J; Vilovic, K1
Bai, Y; Jiang, T; Kong, C; Li, L; Liu, D; Liu, T; Yang, Z1

Other Studies

3 other study(ies) available for butylhydroxybutylnitrosamine and Innate Inflammatory Response

ArticleYear
Persistent γ-H2AX Formation and Expression of Stem Cell Markers in N-Butyl-N-(4-Hydroxybutyl)Nitrosamine-Induced Bladder Carcinogenesis in Rats.
    Toxicological sciences : an official journal of the Society of Toxicology, 2022, 08-25, Volume: 189, Issue:1

    Topics: Animals; Butylhydroxybutylnitrosamine; Carcinogenesis; Histones; Hyperplasia; Inflammation; Nitrosamines; Phosphoproteins; Rats; Stem Cells; Urinary Bladder; Urinary Bladder Neoplasms

2022
The dynamics of the inflammatory response during BBN-induced bladder carcinogenesis in mice.
    Journal of translational medicine, 2019, 11-28, Volume: 17, Issue:1

    Topics: Animals; Butylhydroxybutylnitrosamine; Carcinogenesis; Gene Expression Regulation, Neoplastic; Inflammation; Male; Mice, Inbred C57BL; Urinary Bladder Neoplasms

2019
Knockout of phospholipase Cε attenuates N-butyl-N-(4-hydroxybutyl) nitrosamine-induced bladder tumorigenesis.
    Molecular medicine reports, 2016, Volume: 13, Issue:3

    Topics: Animals; Blotting, Western; Butylhydroxybutylnitrosamine; Carcinogenesis; Cyclooxygenase 2; Fluorescent Antibody Technique; Inflammation; Mice, Inbred C57BL; Mice, Knockout; Neovascularization, Pathologic; Phosphoinositide Phospholipase C; Urinary Bladder; Urinary Bladder Neoplasms; Vascular Endothelial Growth Factor A

2016